首页> 外文期刊>British Journal of Clinical Pharmacology >Publication bias, effects on the assessment of rosiglitasone
【24h】

Publication bias, effects on the assessment of rosiglitasone

机译:出版偏见,对罗格列酮的评估产生影响

获取原文
获取原文并翻译 | 示例
       

摘要

Currently, treatment strategies in clinical pharmacology are almost exclusively based on evidence-based medicine, in particular on randomized placebo controlled double blind trials. An adequate meta-analysis including all available studies is considered the most conclusive proof of efficacy of a given treatment modality. In these systemic reviews, publication bias and related biases can result in misleading conclusions. The funnel-plot is frequently used to detect publication bias and related biases biases.
机译:当前,临床药理学中的治疗策略几乎完全基于循证医学,尤其是基于随机安慰剂对照的双盲试验。包括所有现有研究在内的充分荟萃分析被认为是给定治疗方式疗效的最确凿证据。在这些系统评价中,出版偏见和相关偏见可能导致误导性结论。漏斗图通常用于检测发布偏差和相关偏差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号